Related Experiment Video
Updated: Sep 27, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Comparative Evaluation of Traditional and Emerging Glycemic Biomarkers in Diabetes
Jeremy Jones1, Kyla Frenia2, Kathleen C Garwood3
1Pittsburgh Research Institute, Sewickley, PA 15143, USA.
Abstract:
Diabetes mellitus is a worldwide metabolic disorder that can be debilitating to many if uncontrolled. Biomarkers, such as hemoglobin A1C and glycated albumin, are central to the effort to control diabetes. These each have their own advantages and disadvantages, and there is much ongoing research into development of improved biomarkers and biomarker measurement methods. Continuous glucose monitoring is also widely used to closely monitor diabetes in patients today. Increasingly, however, there has been research focusing on the use of biomarkers in alternative mediums, such as tear fluid or saliva. This review efficiently summarizes the current biomarkers used clinically today, their advantages and disadvantages, and the biomarkers on the horizon that could advance how diabetes is treated in the future.
Related Concept Videos
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational